Skip to content

Efficacy of Lyophilized Human Prothrombin Complex Concentrate on acute patients with hemorrhage: a single arm phase II study

Efficacy of Lyophilized Human Prothrombin Complex Concentrate on acute patients with hemorrhage: a single arm phase II study - Lyophilized Human Prothrombin Complex Concentrate on acute patients: a single arm phase II study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030812
Enrollment
10
Registered
2018-01-15
Start date
2018-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe trauma patients with cerebral hemorrhage, those who were admitted to the Advanced Critical Care and Emergency Center and had less than 2 in PT-INR

Interventions

1) Once during a hospital stay 2) Amount PT-INR &gt
=2, &lt
4: body weight&lt
=100kg = 25IU/kg, body weight&gt
100kg = 2500IU PT-INR &gt
=4, &lt
=6: body weight&lt
=100kg = 35IU/kg, body weight&gt
100kg = 3500IU PT-INR &gt
6: body weight&lt
=100kg = 50IU/kg, body weight&gt
100kg = 5000IU

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Severe trauma patients with cerebral hemorrhage, those who were admitted to the Advanced Critical Care and Emergency Center and had less than 2 in PT-INR

Exclusion criteria

Exclusion criteria: 1) Severe trauma patients with cerebral hemorrhage, those who were admitted to the Advanced Critical Care and Emergency Center and had greater than or equal to 2 in PT-INR 2) Patients, those who were determined by a physician as not-adequate to include the study

Design outcomes

Primary

MeasureTime frame
Changes in hemorrhage between the beginning of medication and hospital discharge

Countries

Japan

Contacts

Public ContactTakashi Kawasaki

Yokohama City University Medical Center Advanced Critical Care and Emergency Center

tks59jn@gmail.com045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026